Free shipping on all orders over $ 500

AT7867

Cat. No. M1654

All AbMole products are for research use only, cannot be used for human consumption.

AT7867 Structure
Size Price Availability Quantity
5mg USD 120 In stock
10mg USD 160 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

AT7867 as a novel and potent inhibitor of both AKT and the downstream kinase p70 S6 kinase (p70S6K) and also of protein kinase A. This ATP-competitive small molecule potently inhibits both AKT and p70S6K activity at the cellular level, as measured by inhibition of GSK3β and S6 ribosomal protein phosphorylation, and also causes growth inhibition in a range of human cancer cell lines as a single agent.

Protocol (for reference only)
Cell Experiment
Cell lines PTEN-negative U87MG human glioblastoma cells
Preparation method Alamar Blue Cell Proliferation Assay.
Cells were plated in 96-well microplates at 5000 cells per well in medium supplemented with 10% FBS, and grown for 24 hours before treatment with AT7867. Inhibitor or vehicle control was added to the cells for 72 hours. Following this, Alamar Blue solution (BioSource, Nivelle Belgium) was added as stated in the manufacturer's instructions. The IC50 value for each inhibitor was calculated in GraphPad Prism (San Diego, USA) using non-linear regression analysis and a sigmoidal dose-response (variable slope) equation.
Concentrations 0~100 μM
Incubation time 72 h
Animal Experiment
Animal models athymic BALB/c mice bearing MES-SA and U87MG human glioblastoma xenograft tumors
Formulation 10% DMSO, 90% saline
Dosages 20mg/kg or 90mg/kg once every 3 days
Administration p.o.
Chemical Information
Molecular Weight 337.85
Formula C20H20ClN3
CAS Number 857531-00-1
Solubility (25°C) DMSO 60 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Grimshaw KM, et al. Mol Cancer Ther. AT7867 is a potent and oral inhibitor of AKT and p70 S6 kinase that induces pharmacodynamic changes and inhibits human tumor xenograft growth.

Related Akt Products
GSK690693

GSK690693 is a potent Akt inhibitor (Akt1 IC50 = 2 nM, Akt2 IC50 = 13 nM, Akt3 IC50 = 9 nM) which also inhibited the phosphorylation of the downstream target GSK3b in cells.

Perifosine

Perifosine is an orally active Akt inhibitor, the antiproliferative properties of Perifosine with an IC50 of 0.6–8.9 µM.

MK-2206 2HCl

MK-2206 is a novel allosteric inhibitor of Akt with IC50 values of 8 nM, 12 nM and 65 nM for Akt1, Akt2 and Akt3, respectively.

Ipatasertib

Ipatasertib (GDC-0068, RG7440) is a potent and selective, ATP-competitive Akt inhibitor with IC50 values of 5 to 18 nM.

Triciribine

Triciribine (API-2, NSC 154020) is a selective inhibitor of Akt (protein kinase B) signaling with IC50 of 130 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: AT7867 supplier, Akt, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.